Table 4 Assessments of tumor response to treatment.

From: Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma

 

ITT population (n = 231)

 

PP population (n = 141)

Chemotherapy, n = 78

Immunochemotherapy, n = 153

P-value

Chemotherapy, n = 48

Immunochemotherapy, n = 93

P-value

Therapeutic evaluation, n (%)

  

 < 0.001

Pathological response, n (%)

  

 < 0.001

 CR

2 (2.6)

4 (2.6)

 

TRG 0

10 (20.8)

39 (41.9)

 

 PR

31 (39.7)

110 (71.9)

 

TRG 1

2 (4.2)

23 (24.7)

 

 SD

40 (51.3)

37 (24.2)

 

TRG 2

36 (75.0)

31 (33.3)

 

 PD

5 (6.4)

2 (1.3)

     
  1. Abbreviations: ITT, intention-to-treat; PP, postoperative; CR, complete remission; PR, partial remission; SD, stable disease; PD, progression disease; TRG, tumor regression grade.
  2. Significant values are in bold.
Back to article page